Previous 10 | Next 10 |
DEERFIELD, Ill., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced its plans to release financial results for its second quarter...
DEERFIELD, Ill., July 20, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced the commercial relaunch of its CervAlign® anterior cervi...
Program to aid in patient access to Surgalign’s Coflex ® Interlaminar Stabilization ® and SImmetry ® SI Joint Fusion Systems DEERFIELD, Ill., July 14, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technolog...
DEERFIELD, Ill., July 06, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced continued momentum in the commercialization of its HOLO Porta...
Surgalign (NASDAQ:SRGA) board and stockholders approved a reverse stock split of issued and outstanding shares of its common stock and also authorized the board to select the ratio of the reverse stock split. The board has exercised such discretion to effect a 1-for-30 reverse stock spli...
DEERFIELD, Ill., May 16, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that at its Annual Meeting of Stockholders (“Annual Mee...
Surgalign Holdings, Inc. (SRGA) Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants David Lyle – Chief Financial Officer Terry Rich – President and Chief Executive Officer Chris Thunander – Chief Accounting Officer Conference Call Participants Br...
Surgalign press release (NASDAQ:SRGA): Q1 Non-GAAP EPS of -$0.07 beats by $0.03. Revenue of $20.61M (-11.5% Y/Y) beats by $1.51M. As of March 31, 2022, cash and cash equivalents were approximately $44.7 million. This compares to $51.3 million reported as of December 31, 2021. Now expects full...
DEERFIELD, Ill., May 10, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced financial results for its 2022 first quarter ended March 31, ...
DEERFIELD, Ill., May 05, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that the Company’s HOLO Portal surgical guidance system...